TCIM
SBBP

TIAA CREF Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

TIAA CREF Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-129,096
Closed -$1.14M – 3153
2018
Q1 		$1.14M Buy
129,096
+68,748
+114% +$515K ﹤0.01% 2373
2017
Q4 		$438K Buy
60,348
+797
+1% +$4.98K ﹤0.01% 2830
2017
Q3 		$411K Sell
59,551
-3,240
-5% -$22.4K ﹤0.01% 2917
2017
Q2 		$449K Buy
+62,791
New +$290K ﹤0.01% 2908

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

TIAA CREF Investment Management's SBBP Position: Q2 2018 in Review

TIAA CREF Investment Management sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2018, closing a stake of 129,096 shares — an estimated $1.14M sold.

TIAA CREF Investment Management first reported a position in SBBP in Q2 2017 and held it in 4 quarters. The position peaked at $1.14M in Q1 2018. 64 funds tracked by Wall St. Rank hold SBBP as of Q2 2018.

  • TIAA CREF Investment Management reported no remaining Strongbridge Biopharma plc. position as of Q2 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 129,096 Strongbridge Biopharma plc. shares in Q2 2018, an estimated $1.14M.
  • TIAA CREF Investment Management first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 4 quarters.
  • TIAA CREF Investment Management's Strongbridge Biopharma plc. position peaked at $1.14M in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2018.

Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.